Stay updated with breaking news from Final Written Decision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Welcome to this issue of The Precedent, which covers those opinions from Q3 and Q4 of 2023 that the Federal Circuit designated as precedential and worthy of publication in the Federal Reporter.
In denying Petitioner Medivis, Inc.'s ("Medivis") Request for Rehearing of the Patent Trial and Appeal Board's ("PTAB") Final Written Decision ("FWD") in
On April 16, 2024, the PTAB proposed new rules (“proposed rules”) governing the Director Review process, which would remain consistent with the Interim review process currently in...
In September 2017, Purdue Pharma L.P. ("Purdue") sued Collegium Pharmaceutical, Inc. ("Collegium") for infringement of US Pat. No. 9,693,961.
Over the past 20 years, the Federal Circuit’s opinion in SuperGuide Corp. v. DirectTV Enters., Inc., 358 F.3d 870 (Fed. Cir. 2004), which defined the plain and ordinary meaning of the...